Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation in non-intubated patients vs placebo
CTR20190909Phase 3Completed
- Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in None, sponsored by Chengdu Brilliant Pharmaceutical Co., Ltd.. Started May 2019; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on CTR20190909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190909.